GPHN p.Asn267Ser

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020806.5(GPHN):​c.800A>G​(p.Asn267Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.007 in 1,608,422 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0059 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0071 ( 57 hom. )

Consequence

GPHN
NM_020806.5 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.305

Publications

14 publications found
Variant links:
Genes affected
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020806.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040991902).
BP6
Variant 14-66924264-A-G is Benign according to our data. Variant chr14-66924264-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 466213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00587 (894/152294) while in subpopulation AMR AF = 0.011 (168/15292). AF 95% confidence interval is 0.00963. There are 2 homozygotes in GnomAd4. There are 453 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020806.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPHN
NM_020806.5
MANE Select
c.800A>Gp.Asn267Ser
missense
Exon 8 of 23NP_065857.1Q9NQX3-2
GPHN
NM_001377514.1
c.768+1326A>G
intron
N/ANP_001364443.1
GPHN
NM_001377515.1
c.729+1326A>G
intron
N/ANP_001364444.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPHN
ENST00000478722.6
TSL:1 MANE Select
c.800A>Gp.Asn267Ser
missense
Exon 8 of 23ENSP00000417901.1Q9NQX3-2
GPHN
ENST00000315266.9
TSL:1
c.729+1326A>G
intron
N/AENSP00000312771.5Q9NQX3-1
GPHN
ENST00000960384.1
c.800A>Gp.Asn267Ser
missense
Exon 8 of 25ENSP00000630443.1

Frequencies

GnomAD3 genomes
AF:
0.00587
AC:
893
AN:
152176
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0110
Gnomad ASJ
AF:
0.00635
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00650
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00775
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00653
AC:
1641
AN:
251212
AF XY:
0.00664
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00721
Gnomad ASJ exome
AF:
0.00486
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00823
Gnomad NFE exome
AF:
0.00822
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.00712
AC:
10372
AN:
1456128
Hom.:
57
Cov.:
28
AF XY:
0.00707
AC XY:
5127
AN XY:
724764
show subpopulations
African (AFR)
AF:
0.00141
AC:
47
AN:
33402
American (AMR)
AF:
0.00739
AC:
330
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00525
AC:
137
AN:
26088
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39662
South Asian (SAS)
AF:
0.00488
AC:
420
AN:
86152
European-Finnish (FIN)
AF:
0.00983
AC:
525
AN:
53396
Middle Eastern (MID)
AF:
0.0193
AC:
111
AN:
5760
European-Non Finnish (NFE)
AF:
0.00751
AC:
8310
AN:
1106752
Other (OTH)
AF:
0.00813
AC:
490
AN:
60238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
500
1000
1501
2001
2501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00587
AC:
894
AN:
152294
Hom.:
2
Cov.:
32
AF XY:
0.00608
AC XY:
453
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00171
AC:
71
AN:
41568
American (AMR)
AF:
0.0110
AC:
168
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00635
AC:
22
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00291
AC:
14
AN:
4818
European-Finnish (FIN)
AF:
0.00650
AC:
69
AN:
10618
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00775
AC:
527
AN:
68022
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00738
Hom.:
8
Bravo
AF:
0.00564
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0106
EpiControl
AF:
0.00884

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A (2)
-
-
1
GPHN-related disorder (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)
-
-
1
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C (1)
-
-
1
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C;C4551954:Hyperekplexia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.048
DANN
Benign
0.44
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.082
N
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-1.1
T
PhyloP100
-0.30
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.32
N
REVEL
Benign
0.089
Sift
Benign
1.0
T
Sift4G
Benign
0.70
T
gMVP
0.32
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41285470;
hg19: chr14-67390981;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.